GENE ONLINE|News &
Opinion
Blog

Global Events
Scaling up Korea’s Biotech Presence in The Global Value Chain, an Interview with Seung Kyou Lee, Vice President of KoreaBIO
2022-08-31
BIOPLUS-INTERPHEX Korea 2022: The Now and Tomorrow of Korea’s Biotechnology Industry
2022-08-15
BIO Asia-Taiwan 2022: Looking for the Exit; Startup Considerations and Strategies
2022-07-28
BIO Asia-Taiwan 2022: Top iPS Cell Technologies at Affordable Prices – Keynote by Nobel Laureate Shinya Yamanaka
2022-07-28
How the Greater Tokyo Region Could Be the Next Promising Biocommunity
2022-07-19
BIO 2022: Challenges in Developing Cell and Gene Therapies
2022-06-23
ASCO 2022: AstraZeneca, Pfizer, Novartis Share Key Data on Breast Cancer Therapeutics
2022-06-07
Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology
2022-05-27
Convergence, Communication and Commercialization, The Cornerstones In Emerging Regulatory Trends
2022-05-24
The First International Biomedical Entrepreneurship Competition Has Announced Its Top 6 Winners
2022-05-23
RNA Therapeutics Beyond Vaccines
2022-05-19
AACR 2022: Stand Up to Cancer, Standing up to Treatment
2022-04-21
Bio-Europe Spring: 2022 Europe Ophthalmic Medication Market Skyrockets
2022-04-20
AACR 2022: Raising Capital for Drugs of the Future- Cell Therapies
2022-04-18
AACR 2022 Opening: Decoding Cancer Complexity to Transform Patient Outcomes
2022-04-12
1 2 3 5
LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!